(Q48477204)

English

Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter tr

scientific article published in July 1985

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter tr (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

Adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

8

object named as

Mella O

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

author name string

Hatlevoll R

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

Lindegaard KF

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

Hagen S

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

Kristiansen K

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

Nesbakken R

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

Torvik A

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

Ganz JC

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

Rosengren B

9

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

Ringkjöb R

10

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

language of work or name

0 references

publication date

1 July 1985

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

56

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

41-47

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819850701%2956%3A1%3C41%3A%3AAID-CNCR2820560108%3E3.0.CO%3B2-W

21 January 2018

Misonidazole and radiotherapy to treat malignant glioma: A phase II trial of the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819850701%2956%3A1%3C41%3A%3AAID-CNCR2820560108%3E3.0.CO%3B2-W

21 January 2018

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus bcnu for treatment of malignant glioma after surgery; Preliminary results of an RTOG study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819850701%2956%3A1%3C41%3A%3AAID-CNCR2820560108%3E3.0.CO%3B2-W

21 January 2018

A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819850701%2956%3A1%3C41%3A%3AAID-CNCR2820560108%3E3.0.CO%3B2-W

21 January 2018

Optimizing the interval between administration of misonidazole and irradiation: an in vitro study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819850701%2956%3A1%3C41%3A%3AAID-CNCR2820560108%3E3.0.CO%3B2-W

21 January 2018

Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819850701%2956%3A1%3C41%3A%3AAID-CNCR2820560108%3E3.0.CO%3B2-W

21 January 2018

Identifiers

10.1002/1097-0142(19850701)56:1<41::AID-CNCR2820560108>3.0.CO;2-W

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/2988737

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48477204&oldid=1189710112"